Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP
September 27, 2023 03:24 ET
|
Chr. Hansen Holding A/S
September 27, 2023 – Company announcement no. 8 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press...
Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion
September 04, 2023 05:48 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Chr. Hansen Holding A/S Interim Report Q3 2022/23
July 06, 2023 02:03 ET
|
Chr. Hansen Holding A/S
July 6, 2023 – Company announcement no. 7 Strong execution by the organization drives solid Q3 results Statement by CEO Mauricio Graber: “The solid results for Q3 prove the strength of the Chr....
Chr. Hansen Holding A/S Interim Report Q2 2022/23
April 13, 2023 02:02 ET
|
Chr. Hansen Holding A/S
April 13, 2023 – Company announcement no. 6 A strong first half supporting the full-year outlook Statement by CEO Mauricio Graber: “The strong results for Q2 confirm the attractiveness of the...
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
March 30, 2023 12:07 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S
March 30, 2023 11:58 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. ...
Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders
March 30, 2023 07:11 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. MARCH 30,...
Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion
March 28, 2023 06:07 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...
Notice to convene Extraordinary General Meeting
March 08, 2023 02:05 ET
|
Chr. Hansen Holding A/S
MARCH 8, 2023 – ANNOUNCEMENT NO. 4 An Extraordinary General Meeting of Chr. Hansen Holding A/S will be held on Thursday, March 30, 2023, at 5:00 p.m. CEST at The Hangar – Clarion...
Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company
March 08, 2023 02:00 ET
|
Chr. Hansen Holding A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH...